Diasome Pharmaceuticals is a startup based in the United States.
Diasome Pharmaceuticals is a company headquartered in the United States.
Diasome Pharmaceuticals is developing liver-targeted metabolic therapies, including insulin formulations that improve glycemic control and reduce hypoglycemia risk in diabetes patients by delivering drugs directly to the portal-hepatic region.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.